NDUFA13 and cancer: Overexpression of GRIM19 has therapeutic properties against cancer by inhibiting STAT3-mediated signal transduction, while the absence of GRIM19 abrogates mitochondrial respiratory chain function and accelerates tumor development by enhancing the expression of STAT3-responsive genes [13–15].